Comparison of fluconazole and ketoconazole in experimental murine blastomycosis.

Fluconazole, a new oral triazole antifungal agent, was tested against Blastomyces dermatitidis in vitro and in a murine model (pulmonary challenge) and compared with ketoconazole, an oral imidazole known to be effective against this agent in mice and in humans. Although fluconazole appeared less active than ketoconazole in vitro, in experiments involving 3 weeks of treatment and 2 months of observation, fluconazole was greater than 10 times as potent (mg/kg) in vivo against blastomycosis (prolongation of life). In the model neither drug was curative at the doses and regimens used. A possible explanation for the efficacy of fluconazole in vivo is its favorable pharmacokinetic profile (i.e., prolonged serum concentrations that exceeded the MIC for the pathogen after oral administration). Dosages of 100 mg/(kg.d) were tolerated for 3 weeks without evident toxicity.

[1]  R. M. Tucker,et al.  Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis , 1988, Antimicrobial Agents and Chemotherapy.

[2]  A. Sugar,et al.  Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice , 1986, Antimicrobial Agents and Chemotherapy.

[3]  M J Humphrey,et al.  Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans , 1985, Antimicrobial Agents and Chemotherapy.

[4]  E. Brummer,et al.  Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis , 1985, Antimicrobial Agents and Chemotherapy.

[5]  E. Brummer,et al.  Study of current and new drugs in a murine model of acute paracoccidioidomycosis. , 1985, The American journal of tropical medicine and hygiene.

[6]  T. Blaschke,et al.  Disposition of ketoconazole, an oral antifungal, in humans , 1982, Antimicrobial Agents and Chemotherapy.

[7]  D. Stevens,et al.  Molecular Modifications of Imidazole Compounds: Studies of Activity and Synergy in Vitro and of Pharmacology and Therapy of Blastomycosis in a Mouse Model , 1980 .

[8]  D. Stevens,et al.  Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters. , 1978, The American review of respiratory disease.

[9]  J. Galgiani,et al.  Antimicrobial Susceptibility Testing of Yeasts: a Turbidimetric Technique Independent of Inoculum Size , 1976, Antimicrobial Agents and Chemotherapy.